Home › Funds › BVF INC/IL › ELDN
BVF INC/IL position in ELDN
ELEDON PHARMACEUTICALS INC · Health Care
BVF INC/IL reported holding 6,293,282 shares of ELDN (ELEDON PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$24.8M, representing 0.63% of its reported portfolio and ranking #31 among its reported holdings. BVF INC/IL has disclosed ELDN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BVF INC/IL's ELDN position evolved
BVF INC/IL first disclosed a stake in ELDN in Q3 2023 at 4,326,710 shares (US$5.9M). The position peaked in Q4 2024 at 6,293,282 shares, worth US$25.9M. Across 12 filings, BVF INC/IL increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 6,293,282 shares valued at US$24.8M. Notable position changes include a 45% increase in Q2 2024 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.33M | $5.93M | New |
| Q4 2023 | 4.33M | $7.79M | Hold |
| Q1 2024 | 4.33M | $8.91M | Hold |
| Q2 2024 | 6.29M | $16.61M | Add |
| Q3 2024 | 6.29M | $15.67M | Hold |
| Q4 2024 | 6.29M | $25.93M | Hold |
| Q1 2025 | 6.29M | $21.33M | Hold |
| Q2 2025 | 6.29M | $17.05M | Hold |
| Q3 2025 | 6.29M | $16.30M | Hold |
| Q4 2025 | 6.29M | $9.50M | Hold |
| Q1 2026 | 6.29M | $19.38M | Hold |
| Q2 2026 | 6.29M | $24.80M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELDN and 13F data
ELDN (ELEDON PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ELDN — the largest reported positions include Defilade Capital Management, L.P. (US$13.9M), Catalio Capital Management, LP (US$6.7M), SPHERA FUNDS MANAGEMENT LTD. (US$4.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELDN
- Defilade Capital Management, L.P. 3.53M sh · $13.89M · Q2 2026
- Catalio Capital Management, LP 1.70M sh · $6.68M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 1.19M sh · $4.69M · Q2 2026
- 22NW, LP 636.36K sh · $2.51M · Q2 2026
- CM Management, LLC 575.00K sh · $2.27M · Q2 2026
FAQ
How long has BVF INC/IL held ELDN?
BVF INC/IL has disclosed ELDN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BVF INC/IL's current position in ELDN?
As of Q2 2026, BVF INC/IL holds 6.29M shares of ELDN (ELEDON PHARMACEUTICALS INC), valued at $24.80M, representing 0.63% of its reported portfolio and ranking #31.
Has BVF INC/IL been buying or selling ELDN?
In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in ELDN. The position peaked in Q4 2024 at 6.29M shares.
Which other funds hold ELDN?
Other major institutional holders of ELDN include Defilade Capital Management, L.P., Catalio Capital Management, LP, SPHERA FUNDS MANAGEMENT LTD., among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.